Article Details

Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the ...

Retrieved on: 2018-05-02 17:56:15

Tags for this article:

Click the tags to see associated articles and topics

Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the .... View article details on hiswai:

Excerpt

<div>Bob Tepper, the interim CSO, is a co-founder of <b>Third Rock Ventures</b> and previous president of R&D at Millennium Pharmaceuticals. Cary Pfeffer, the interim CBO, is a partner at <b>Third Rock Ventures</b> and has assumed leadership roles in multiple portfolio companies, including Rheos Medicines, Neon ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up